您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > TH-6
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
TH-6
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
TH-6图片
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
TH-6 是一种有效的HDAC抑制剂,对 HDAC1、HDAC2、HDAC3、HDAC6、HDAC8 的IC50分别为 0.115、0.135、0.242、0.138、2.120 μM。TH-6 抑制细胞迁移和侵袭。TH-6 诱导细胞凋亡 (apoptosis)和细胞周期停滞在 G2/M 期。TH-6 显示出抗肿瘤活性。
生物活性

TH-6 is a potentHDACinhibitor withIC50s of 0.115, 0.135, 0.242, 0.138, 2.120 μM forHDAC1,HDAC2,HDAC3,HDAC6,HDAC8, respectively. TH-6 inhibits cell migration and invasion. TH-6 inducesapoptosisand cell cycle arrest at G2/M phase. TH-6 shows anti-tumor activity[1].

IC50& Target[1]

HDAC1

0.115 μM (IC50)

HDAC2

0.135 μM (IC50)

HDAC3

0.242 μM (IC50)

HDAC6

0.138 μM (IC50)

HDAC8

2.120 μM (IC50)

体外研究
(In Vitro)

TH-6 (0-2 μM) shows antiproliferative activities in cancer cell lines and normal human lung cells[1].
TH-6 (0-10 μM) inhibits tubulin polymerization with an IC50value of 4.06 μM[1].
TH-6 (0.03, 0.1, 0.3 1 μM; 24 h) increases the expression of Ac-α-Tubulin and AC-Histone H3 in HepG2 cells[1].
TH-6 (7.5, 15, 30 nM) induces apoptosis and cell cycle arrest at G2/M phase[1].
TH-6 (0-30 nM) decreases the MMP and increase ROS levels of HepG2 cells in a dose-dependent manner[1].
TH-6 (7.5, 15, 30 nM; 48 h) inhibits cell migration and invasion in MDA-MB-231 cells and suppress the migration of HUVECs in a concentration-dependent manner[1].
TH-6 shows favorable liver microsomal stability in vitro with t1/2of 50.3 min[1].

Cell Viability Assay[1]

Cell Line:K562, GepG2, HCT-116, MDA-MB-231, H22, MCF-7, HFL-1 cells
Concentration:0-2 μM
Incubation Time:
Result:Showed antiproliferative activities with an IC50values of 18, 29, 28, 30, 26, 27, 134 nM for K562, GepG2, HCT-116, MDA-MB-231, H22, MCF-7, HFL-1 cells, respectively.

Western Blot Analysis[1]

Cell Line:HepG2 cells
Concentration:0.03, 0.1, 0.3 1 μM
Incubation Time:24 h
Result:Increased the intracellular levels of HDAC6 substrate acetyl-α-tubulin and the HDAC1/2/3 substrate acetyl-histone H3 in a dose-dependent manner.

Cell Cycle Analysis[1]

Cell Line:HepG2 cells
Concentration:7.5, 15, 30 nM
Incubation Time:
Result:Induced cell cycle arrest at G2/M phase with decreased the expression of Cdc2, Cdc25c, and Cyclin B1 proteins in a dose dependent manner.

Apoptosis Analysis[1]

Cell Line:HepG2 cells
Concentration:7.5, 15, 30 nM
Incubation Time:
Result:Showed an accumulation of apoptotic cells from 27.04 to 50.54% and upregulated the expression of the pro-apoptotic protein (Bax and Bad) and downregulated the expression of the antiapoptotic protein (Bcl-2 and Bcl-xL) in a dose-dependent manner.
体内研究
(In Vivo)

TH-6 (10, 20 mg/kg; i.v.; daily for 21 days) shows anti-tumor activity in mouse[1].
TH-6 (20 mg/kg) shows antivascular activity and a good cardiovascular safety profile in mouse[1].

Animal Model:4-5 weeks, 18-22 g female ICR mice (H22 allograft mouse model)[1]
Dosage:10, 20 mg/kg
Administration:I.v.; daily for 21 days
Result:Reduced tumor weights at day 21 by 82% and did not affect body weight during treatment, indicating the low toxicity.
分子量

429.44

Formula

C22H24FN3O5

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.